GC
KYNB

Guggenheim Capital’s Kyntra Bio KYNB Stock Holding History

Guggenheim Capital’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-821
Closed -$267K – 1936
2022
Q3 		$267K Sell
821
-44
-5% -$14.2K ﹤0.01% 1701
2022
Q2 		$228K Sell
865
-77
-8% -$19.7K ﹤0.01% 1895
2022
Q1 		$283K Buy
942
+49
+5% +$17.1K ﹤0.01% 1911
2021
Q4 		$315K Buy
893
+28
+3% +$8.72K ﹤0.01% 1848
2021
Q3 		$221K Sell
865
-20
-2% -$7.09K ﹤0.01% 2029
2021
Q2 		$589K Buy
885
+40
+5% +$23K ﹤0.01% 1769
2021
Q1 		$733K Buy
845
+403
+91% +$429K ﹤0.01% 1533
2020
Q4 		$410K Sell
442
-1,721
-80% -$1.81M ﹤0.01% 1711
2020
Q3 		$2.22M Sell
2,163
-596
-22% -$641K 0.02% 846
2020
Q2 		$2.8M Buy
2,759
+505
+22% +$469K 0.02% 737
2020
Q1 		$1.96M Sell
2,254
-442
-16% -$439K 0.02% 797
2019
Q4 		$2.89M Buy
2,696
+241
+10% +$246K 0.02% 890
2019
Q3 		$2.27M Sell
2,455
-51
-2% -$56K 0.02% 959
2019
Q2 		$2.83M Buy
2,506
+9
+0.4% +$9.85K 0.02% 899
2019
Q1 		$3.39M Sell
2,497
-78
-3% -$106K 0.03% 822
2018
Q4 		$2.98M Sell
2,575
-365
-12% -$410K 0.03% 833
2018
Q3 		$4.46M Buy
2,940
+80
+3% +$123K 0.03% 784
2018
Q2 		$4.47M Sell
2,860
-122
-4% -$159K 0.03% 793
2018
Q1 		$3.44M Sell
2,982
-270
-8% -$356K 0.01% 1246
2017
Q4 		$3.85M Buy
3,252
+2,861
+732% +$3.59M 0.01% 1186
2017
Q3 		$524K Buy
+391
New +$412K ﹤0.01% 2373

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's KYNB Position: Q4 2022 in Review

Guggenheim Capital sold out of Kyntra Bio (KYNB) in Q4 2022, closing a stake of 821 shares — an estimated $267K sold.

Guggenheim Capital first reported a position in KYNB in Q3 2017 and held it in 21 quarters. The position peaked at $4.47M in Q2 2018. 144 funds tracked by Wall St. Rank hold KYNB as of Q4 2022.

  • Guggenheim Capital reported no remaining Kyntra Bio position as of Q4 2022 after selling out during the quarter.
  • Guggenheim Capital sold 821 Kyntra Bio shares in Q4 2022, an estimated $267K.
  • Guggenheim Capital first reported a position in Kyntra Bio in Q3 2017 and held it in 21 quarters.
  • Guggenheim Capital's Kyntra Bio position peaked at $4.47M in Q2 2018.
  • 144 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.